Cargando…
Cisplatin‐induced programmed cell death ligand‐2 expression is associated with metastasis ability in oral squamous cell carcinoma
Programmed cell death ligands (PD‐Ls) are expressed in tumor cells where they bind to programmed cell death‐1, an immunocyte co–receptor, resulting in tumor cell evasion from the immune system. Chemotherapeutic drugs have been recently reported to induce the expression of PD‐L, such as PD‐L1, in som...
Autores principales: | Sudo, Shunichi, Kajiya, Hiroshi, Okano, Shinji, Sasaki, Mina, Katsumata, Yuri, Ohno, Jun, Ikebe, Tetsuro, Hiraki, Akimitsu, Okabe, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156784/ https://www.ncbi.nlm.nih.gov/pubmed/32012401 http://dx.doi.org/10.1111/cas.14336 |
Ejemplares similares
-
Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour.
por: Hiraki, A., et al.
Publicado: (1996) -
Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma
por: Naganuma, Kaori, et al.
Publicado: (2014) -
Kinetic Analysis of Combination Effect of Navelbine (KW‐2307) with Cisplatin against Human Lung Adenocarcinoma PC‐12 Cells in Culture
por: Gomi, Katsushige, et al.
Publicado: (1992) -
Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
por: Kurata, Atsushi, et al.
Publicado: (2021) -
Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma
por: Harada, Hiroyuki, et al.
Publicado: (2013)